Evidence map›Paper›PMID 37578898›Full record

ArticleAmerican journal of respiratory cell and molecular biology2023

Endogenous and Therapeutic 25-Hydroxycholesterols May Worsen Early SARS-CoV-2 Pathogenesis in Mice.

Michael B Fessler, Jennifer H Madenspacher, Paul J Baker, Kerry L Hilligan, Andrea C Bohrer, Ehydel Castro, Julie Meacham, Shih-Heng Chen, Reed F Johnson, Jeffrey G McDonald and 5 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. The Importance of "Negative" Results: Lipid Lessons in Coronavirus Biology.American journal of respiratory cell and molecular biology · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 4 countries.

Michael B FesslerImmunity, Inflammation and Disease Laboratory.
Jennifer H MadenspacherImmunity, Inflammation and Disease Laboratory.
Paul J BakerInflammation and Innate Immunity Unit.
Kerry L HilliganImmunobiology Section, and.
Andrea C BohrerInflammation and Innate Immunity Unit.
Ehydel CastroInflammation and Innate Immunity Unit.
Julie MeachamImmunity, Inflammation and Disease Laboratory.
Shih-Heng ChenViral Vector Core Facility, Neurobiology Laboratory.
Reed F JohnsonSARS-CoV-2 Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Jeffrey G McDonaldDepartment of Molecular Genetics and.
Negin P MartinViral Vector Core Facility, Neurobiology Laboratory.
Charles J TuckerFluorescence Microscopy and Imaging Center, Signal Transduction Laboratory, and.
Debabrata MahapatraIntegrated Laboratory Systems, LLC, Research Triangle Park, North Carolina.
Mark CestaDivision of the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina.
Katrin D Mayer-BarberInflammation and Innate Immunity Unit.
Institute of Infection and Immunity · CAInnate Pharma (France) · FRState Research Center of Virology and Biotechnology VECTOR · RUFluor (United States) · USImmunité et Cancer · FRIntegrated Laboratory Systems, Inc. · USNational Institute of Allergy and Infectious Diseases · USNational Institutes of Health · USThe University of Texas Southwestern Medical Center · US

Funding

UT Southwestern Center for Translational MedicineUL1TR003163 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2021 to 2025
$39.3M
Pathology Services Supporting the Division Translational ToxicologyZICES103376 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI CESTA, MARK · 2022 to 2025
$23.9M
Tissue Culture & Antibody Production CoreP01HL160487 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI Arun Radhakrishnan · 2022 to 2026
$14.9M
UT Southwestern NORCP30DK127984 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI JAY D. HORTON · 2022 to 2026
$7.4M
Cell Signaling of Host DefenseZ01ES102005 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI FESSLER, MICHAEL B · 2006 to 2008
$3.3M
Mechanisms of sexual Zika virus transmission and early immunopathogenesisR21AI129303 · NIAID · UNIVERSITY OF WASHINGTON · PI VOJTECH, LUCIA N · 2017 to 2018
$426k
Genetic and metabolic effects on ANGPTL8 expression and HDL-C metabolismF31HL127984 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CANNON, MAREN ETTINGER · 2015 to 2017
$85k
Intramural NIH HHS Z01 ES102005NCATS NIH HHS UL1 TR003163NHLBI NIH HHS 1P30DK127984NHLBI NIH HHS P01 HL160487NIAID NIH HHS R21 AI129303NIDDK NIH HHS 5P01HL160487NIDDK NIH HHS P30 DK127984NIEHS NIH HHS ES103316NIEHS NIH HHS Z01 ES102005
6 · The paper itself

Abstract

Oxysterols (i.e., oxidized cholesterol species) have complex roles in biology. 25-Hydroxycholesterol (25HC), a product of the activity of cholesterol-25-hydroxylase (CH25H) on cholesterol, has recently been shown to be broadly antiviral, suggesting therapeutic potential against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, 25HC can also amplify inflammation and be converted by CYP7B1 (cytochrome P450 family 7 subfamily B member 1) to 7α,25-dihydroxycholesterol, a lipid with chemoattractant activity, via the G protein-coupled receptor EBI2 (Epstein-Barr virus-induced gene 2)/GPR183 (G protein-coupled receptor 183). Here, using

Indexed as

COVID-19Epstein-Barr Virus InfectionsAnimalsAntiviral AgentsCholesterolCytokinesHerpesvirus 4, HumanHumansHydroxycholesterolsMicePiperazinesReceptors, G-Protein-CoupledSARS-CoV-2Weight Loss25-hydroxycholesterolAntiviral AgentsCholesterolCytokinesGpr183 protein, mouseHydroxycholesterolsNIBR189PiperazinesReceptors, G-Protein-Coupled25-hydroxycholesterolcholesterol-25-hydroxylaseEBI2pneumoniaSARS-CoV-2

Identifiers

PMID37578898
PMCPMC10704115
OpenAlexW4385805223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.